peptide vs semaglutide Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor agonists (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults Liraglutide vs Semaglutide: Comparing Weight
Description
5 In addition, up to 46% of participants achieved an A1C below 5.7%, the threshold for normoglycemia
Semaglutide's positive effects for PAD appeared to be only weakly linked to weight loss
Shipping Information
[DOI] [PMC free article] [PubMed] [Google Scholar] 166.Neeland I.J., Linge J., Birkenfeld A.L
The pivotal trials for both diabetes and weight management (SUSTAIN and STEP programs) excluded pregnant women and required contraception during participation, limiting our understanding of fertility effects
